The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...

The protein-based vaccine, called Nuvaxovid, has been reformulated to target the JN.1 subvariant of Omicron. Nicole Ireland, The Canadian Press Sep 19, 2024 1:32 PM Sep 19, 2024 1:35 PM Share by Email ...

F protein-subunit based vaccines, adjuvants & potency Both prefusion ... antibody levels and to elicit a Th1 immune response. Novavax is testing a postfusion F protein vaccine formulated with ...

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...

Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide Novavax's updated vaccine is the only protein-based option available in the U.S. this fall ...

Novavax, Inc. (NVAX) announced Friday that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

Health Canada has authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus. The protein-based vaccine, called Nuvaxovid, has been ...

The agency is still reviewing Pfizer’s updated mRNA vaccine, Comirnaty, and has said a decision is expected soon. Novavax has touted its protein-based formulation as an alternative to the two ...